# Amneal Pharmaceuticals Inc. (AMRX) — Operating Income

## Annual Operating Income (USD)

| Year | Operating Income |
| --- | --- |
| 2025 | $394M |
| 2024 | $249M |
| 2023 | $204M |
| 2022 | -$95M |
| 2021 | $153M |
| 2020 | $91M |
| 2019 | -$249M |
| 2018 | -$20M |
| 2017 | $245M |
| 2016 | $285M |

## Quarterly Operating Income (USD)

| Quarter | Operating Income |
| --- | --- |
| 2026-03-31 | $142M |
| 2025-09-30 | $70M |
| 2025-06-30 | $111M |
| 2025-03-31 | $100M |
| 2024-09-30 | $89M |
| 2024-06-30 | $95M |
| 2024-03-31 | -$11M |
| 2023-09-30 | $76M |
| 2023-06-30 | $80M |
| 2023-03-31 | $34M |
| 2022-09-30 | $44M |
| 2022-06-30 | -$199M |
| 2022-03-31 | $23M |
| 2021-09-30 | $29M |
| 2021-06-30 | $67M |
| 2021-03-31 | $46M |
| 2020-09-30 | $2M |
| 2020-06-30 | $11M |
| 2020-03-31 | $58M |
| 2019-09-30 | -$112M |
| 2019-06-30 | -$19M |
| 2019-03-31 | -$94M |
| 2018-09-30 | $75M |
| 2018-06-30 | -$181M |

Source: [MarketCapTrends](https://marketcaptrends.com/company/AMRX/operating-income)